Company Details
tempusai
1,001-5,000 employees
102,957
541714
tempus.com
0
TEM_2104715
In-progress

Tempus AI Company CyberSecurity Posture
tempus.comTempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data. We enable physicians to make real-time, data-driven decisions to deliver personalized care and targeted therapies for patients through our analytical machine learning platform that uses the power of artificial intelligence in healthcare. We also work with partners to facilitate discovery, development, and delivery of optimized therapeutic options for patients through distinctive solution sets. Our mission is for each patient to benefit from the treatment of others who came before by providing the healthcare industry tools that learn as we gather more data. It’s About Time. For more information, visit tempus.com and follow us on Twitter (@TempusLabs).
Company Details
tempusai
1,001-5,000 employees
102,957
541714
tempus.com
0
TEM_2104715
In-progress
Between 750 and 799

Tempus AI Global Score (TPRM)XXXX



No incidents recorded for Tempus AI in 2025.
No incidents recorded for Tempus AI in 2025.
No incidents recorded for Tempus AI in 2025.
Tempus AI cyber incidents detection timeline including parent company and subsidiaries

Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data. We enable physicians to make real-time, data-driven decisions to deliver personalized care and targeted therapies for patients through our analytical machine learning platform that uses the power of artificial intelligence in healthcare. We also work with partners to facilitate discovery, development, and delivery of optimized therapeutic options for patients through distinctive solution sets. Our mission is for each patient to benefit from the treatment of others who came before by providing the healthcare industry tools that learn as we gather more data. It’s About Time. For more information, visit tempus.com and follow us on Twitter (@TempusLabs).


NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness an
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to eac
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in v

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals w
Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to eva
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,
.png)
Per Cornell Jeb E. Brooks School of Public Policy report, the healthcare landscape is constantly evolving, shaped by advances in technology,...
Tempus AI (TEM) remains unprofitable, with its net profit margin showing no improvement over the past year and annual losses having...
The medical diagnostic company, which is developing new AI-driven tests, has at times been a favorite of retail investors....
Tempus AI (TEM) has caught the attention of investors this week after reporting stronger than expected quarterly sales and margins.
There's no doubt about it. The technology sector has been a great place to invest for decades. Indeed, since 2010, the tech-heavy Nasdaq...
Salt AI secured $10M in funding led by Morpheus Ventures to expand its contextual AI platform for life sciences and health tech.
Tempus AI, Inc. (NASDAQ:TEM) is one of the 11 Best Performing IPOs in the Last 2 Years. The stock's price target is raised following a...
Tempus is a technology company leading the adoption of AI to advance precision medicine and patient care.
The opportunity for Tempus AI may not stop at a 2x return. It could potentially be a 10x story or more.

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Tempus AI is http://www.tempus.com.
According to Rankiteo, Tempus AI’s AI-generated cybersecurity score is 785, reflecting their Fair security posture.
According to Rankiteo, Tempus AI currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Tempus AI is not certified under SOC 2 Type 1.
According to Rankiteo, Tempus AI does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Tempus AI is not listed as GDPR compliant.
According to Rankiteo, Tempus AI does not currently maintain PCI DSS compliance.
According to Rankiteo, Tempus AI is not compliant with HIPAA regulations.
According to Rankiteo,Tempus AI is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Tempus AI operates primarily in the Biotechnology Research industry.
Tempus AI employs approximately 1,001-5,000 employees people worldwide.
Tempus AI presently has no subsidiaries across any sectors.
Tempus AI’s official LinkedIn profile has approximately 102,957 followers.
Tempus AI is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).
No, Tempus AI does not have a profile on Crunchbase.
Yes, Tempus AI maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/tempusai.
As of November 27, 2025, Rankiteo reports that Tempus AI has not experienced any cybersecurity incidents.
Tempus AI has an estimated 4,337 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, Tempus AI has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
Angular is a development platform for building mobile and desktop web applications using TypeScript/JavaScript and other languages. Prior to versions 19.2.16, 20.3.14, and 21.0.1, there is a XSRF token leakage via protocol-relative URLs in angular HTTP clients. The vulnerability is a Credential Leak by App Logic that leads to the unauthorized disclosure of the Cross-Site Request Forgery (XSRF) token to an attacker-controlled domain. Angular's HttpClient has a built-in XSRF protection mechanism that works by checking if a request URL starts with a protocol (http:// or https://) to determine if it is cross-origin. If the URL starts with protocol-relative URL (//), it is incorrectly treated as a same-origin request, and the XSRF token is automatically added to the X-XSRF-TOKEN header. This issue has been patched in versions 19.2.16, 20.3.14, and 21.0.1. A workaround for this issue involves avoiding using protocol-relative URLs (URLs starting with //) in HttpClient requests. All backend communication URLs should be hardcoded as relative paths (starting with a single /) or fully qualified, trusted absolute URLs.
Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Uncontrolled Recursion vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft deep ASN.1 structures that trigger unbounded recursive parsing. This leads to a Denial-of-Service (DoS) via stack exhaustion when parsing untrusted DER inputs. This issue has been patched in version 1.3.2.
Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Integer Overflow vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft ASN.1 structures containing OIDs with oversized arcs. These arcs may be decoded as smaller, trusted OIDs due to 32-bit bitwise truncation, enabling the bypass of downstream OID-based security decisions. This issue has been patched in version 1.3.2.
Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. Prior to versions 7.0.13 and 8.0.2, working with large buffers in Lua scripts can lead to a stack overflow. Users of Lua rules and output scripts may be affected when working with large buffers. This includes a rule passing a large buffer to a Lua script. This issue has been patched in versions 7.0.13 and 8.0.2. A workaround for this issue involves disabling Lua rules and output scripts, or making sure limits, such as stream.depth.reassembly and HTTP response body limits (response-body-limit), are set to less than half the stack size.
Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. In versions from 8.0.0 to before 8.0.2, a NULL dereference can occur when the entropy keyword is used in conjunction with base64_data. This issue has been patched in version 8.0.2. A workaround involves disabling rules that use entropy in conjunction with base64_data.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.